Chromogenex Releases Regenlite Transform

December 21, 2014

The latest addition to the Chromogenex family, Regenlite Transform is now available. It is specifically designed for managing inflammatory skin conditions without any discomfort, downtime or residual cell necrosis, the company says.

A pure 585nm laser offers 300% more absorption in Oxyhaemoglobin than the usual 595nm laser, the company says. SmartPulse technology maximizes collagen stimulation without causing long-term impairment. Regenlite Transform requires less energy and is less painful than other aesthetic devices in treating a wide range of skin conditions.

Chromogenex says the device’s biostimulatory effect in the tissue stimulates important cytokines that can resolve the active dermatological disorder. These cytokines, which can increase by up to 1500% above normal tissue levels, have been measured as soon as 3 hours after the laser treatment, demonstrating the ability for rapid relief of these inflammatory conditions. This unique biostimulatory effect in the tissue enhances the skin’s wound healing response over and above the normal levels of response without having to create a trauma unlike the mechanism of most laser and light therapies.

According to data reported by Chromogenex, A single Regenlite Transform treatment on acne vulgaris can decrease the average number of acne lesions by 50%.

  • Improvement has been observed to last longer than 12 weeks after a single laser session.
  • 87% of patients demonstrated substantial improvement
  • 58% exhibited greater than 50% improvement.

Facebook Comments


We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free